200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 129468-28-6
129468-28-6 | Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5α)-
CAS No: 129468-28-6 Catalog No: AG000Z5P MDL No:
Product Description
Catalog Number:
AG000Z5P
Chemical Name:
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5α)-
CAS Number:
129468-28-6
Molecular Formula:
C27H27NO4
Molecular Weight:
429.5076
IUPAC Name:
(4R,4aS,6E,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
InChI:
InChI=1S/C27H27NO4/c29-20-9-8-18-13-21-27(31)14-19(12-16-4-2-1-3-5-16)23(30)25-26(27,22(18)24(20)32-25)10-11-28(21)15-17-6-7-17/h1-5,8-9,12,17,21,25,29,31H,6-7,10-11,13-15H2/b19-12+/t21-,25+,26+,27-/m1/s1
InChI Key:
WXOUFNFMPVMGFZ-BDQAUFNLSA-N
SMILES:
O=C1C(=Cc2ccccc2)C[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O
Properties
Complexity:
832
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
4
Defined Bond Stereocenter Count:
1
Exact Mass:
429.194g/mol
Formal Charge:
0
Heavy Atom Count:
32
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
429.516g/mol
Monoisotopic Mass:
429.194g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
70A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4
Literature
| Title | Journal |
|---|---|
| Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi. | Bioorganic & medicinal chemistry letters 20120815 |
| Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi. | Bioorganic & medicinal chemistry letters 20110815 |
| Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels. | Bulletin of experimental biology and medicine 20101001 |
| Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. | Biological psychiatry 20090115 |
| Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. | European journal of pharmacology 20080531 |
| Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors. | Neuropeptides 20080401 |
| Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice. | The Journal of pharmacology and experimental therapeutics 20070701 |
| Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment. | The Journal of pharmacology and experimental therapeutics 20070501 |
| Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity. | Journal of medicinal chemistry 20070419 |
| Repeated delta1-opioid receptor stimulation reduces delta2-opioid receptor responses in the SA node. | American journal of physiology. Heart and circulatory physiology 20061101 |
| The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation. | American journal of physiology. Heart and circulatory physiology 20061101 |
| ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects. | The Journal of pharmacology and experimental therapeutics 20060101 |
| delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. | Life sciences 20051119 |
| Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. | Psychopharmacology 20051101 |
| Involvement of delta1-opioid receptors in the spatial learning impairment in streptozotocin-induced diabetic mice. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20051001 |
| In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. | The Journal of pharmacology and experimental therapeutics 20050601 |
| Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. | Neuroscience 20050101 |
| A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. | Journal of medicinal chemistry 20040603 |
| Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms. | European journal of pharmacology 20040426 |
| Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. | Cardiovascular research 20040215 |
| Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus. | Bulletin of experimental biology and medicine 20040201 |
| Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa. | British journal of pharmacology 20031001 |
| Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. | American journal of physiology. Heart and circulatory physiology 20030701 |
| Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node. | American journal of physiology. Heart and circulatory physiology 20030501 |
| Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. | European journal of pharmacology 20030425 |
| Modulation of myofilament Ca2+ densitivity by delta- and kappa-opioid agonists in intact guinea pig hearts. | Anesthesia and analgesia 20030301 |
| Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. | American journal of physiology. Heart and circulatory physiology 20021101 |
| Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. | The Journal of pharmacology and experimental therapeutics 20021101 |
| Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. | European journal of pharmacology 20010921 |
| Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity. | The Journal of pharmacology and experimental therapeutics 20010901 |
| Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. | The Journal of thoracic and cardiovascular surgery 20010901 |
| Essential role of oxygen radicals in delayed pharmacological preconditioning. | Journal of molecular and cellular cardiology 20010801 |
| BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. | Journal of molecular and cellular cardiology 20010801 |
| Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. | Journal of neurochemistry 20010601 |
| Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. | Anesthesiology 20010601 |
| Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia. | The Journal of pharmacology and experimental therapeutics 20010501 |
| Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa. | The Journal of pharmacology and experimental therapeutics 20010501 |
| The role of delta-opioid receptor subtypes in neuropathic pain. | European journal of pharmacology 20010309 |
| Essential activation of PKC-delta in opioid-initiated cardioprotection. | American journal of physiology. Heart and circulatory physiology 20010301 |
| Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. | American journal of physiology. Heart and circulatory physiology 20010101 |
| G-protein-coupled receptor heterodimerization modulates receptor function. | Nature 19990617 |
| Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. | Brain research 19970516 |
| Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety. | Journal of medicinal chemistry 19940304 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.